Targeted deletion of three CYP51s in Fusarium fujikuroi and their different roles in determining sensitivity to 14α‐demethylase inhibitor fungicides
Pest Management Science · 2023-04 · 79 (4) · 1324-1330
DOI: 10.1002/ps.7304 ↗At a glance
Journal article in Pest Management Science, published online on 2022-12-02. Written by Cheng-Xin Mao and 3 co-authors. Institution: Department of Crop Protection, Zhejiang Agriculture and Forest University, Hangzhou, China. Major MEDLINE topics: Fungicides, Industrial, Fusarium. Cited 29 times so far (Crossref); 49 references. Funded by: China National Tobacco Corporation, Key Research and Development Project of Zhejiang Province, 'Sannongliufang' Research Joint Project of Zhejiang Province.
Abstract (original language)
Background
Fusarium fujikuroi is the pathogenic agent of rice bakanae disease and has developed serious resistance to prochloraz, a 14α‐demethylase inhibitor (DMI). Prochloraz resistance in F . fujikuroi is caused by cooperation between FfCyp51B with Cyp51A and shows cross‐resistance only to prothioconazole but not to tebuconazole, difenoconazole, propiconazole, metconazole, hexaconazole, and triadimefon. This study aimed to analyze the functions of the three Cyp51s in F . fujikuroi , especially their role in determining sensitivity to DMIs.
Results
The respective deletion of FfCyp51A , Cyp51B , and Cyp51C had no obvious effect on morphology, conidium germination, or pathogenicity. The involvement of growth, growth and ergosterol biosynthesis, and conidium production and ergosterol biosynthesis was observed for FfCyp51A , Cyp51B , and Cyp51C , respectively. Compared with the sensitive isolate of F. fujikuroi , the effect on sensitivity to the tested DMIs was divided into four groups: (i) both of Cyp51A and Cyp51B positively regulate the sensitivity to prochloraz and prothioconazole; (ii) Cyp51B positively regulate the sensitivity to tebuconazole and metconazole, but negatively regulate the sensitivity to difenoconazole; (iii) Cyp51A and Cyp51B play opposite roles in the sensitivity to triadimefon. Therefore, deletion of Cyp51A in F . fujikuroi confers a higher sensitivity to triadimefon, while deletion of Cyp51B results in a triadimefon‐resistant mutant isolate; (iv) deletion of Cyp51B yielded a mutant isolate that was more resistant to propiconazole and hexaconazole.
Conclusion
Sophisticated interactions exist within the three Cyp51 genes to DMIs fungicides sensitivity in F. fujikuroi , and Cyp51B probably plays a more critical role than Cyp51A and Cyp51C. © 2022 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Crop Protection, Zhejiang Agriculture and Forest University, Hangzhou, China.
- State Key Laboratory of Rice Biology, China National Rice Research Institute, Hangzhou, China.
ORCID profiles: Chuan-Qing Zhang
Funding
- China National Tobacco Corporation
- Key Research and Development Project of Zhejiang Province
- 'Sannongliufang' Research Joint Project of Zhejiang Province
- Zhejiang Provincial Natural Science Foundation
- Natural Science Foundation of Zhejiang Province
Cite
APA
Mao, C. X., Luo, J., Zhang, Y., & Zhang, C. Q. (2023). Targeted deletion of three CYP51s in Fusarium fujikuroi and their different roles in determining sensitivity to 14α‐demethylase inhibitor fungicides. Pest Management Science, 79(4), 1324-1330. https://doi.org/10.1002/ps.7304
Vancouver
Mao CX, Luo J, Zhang Y, Zhang CQ. Targeted deletion of three CYP51s in Fusarium fujikuroi and their different roles in determining sensitivity to 14α‐demethylase inhibitor fungicides. Pest Management Science. 2023;79(4):1324-1330. doi:10.1002/ps.7304
BibTeX
@article{Mao2023,
author = {Mao, Cheng-Xin and Luo, Ju and Zhang, Yu and Zhang, Chuan-Qing},
title = {Targeted deletion of three CYP51s in Fusarium fujikuroi and their different roles in determining sensitivity to 14α‐demethylase inhibitor fungicides},
journal = {Pest Management Science},
year = {2023},
volume = {79},
number = {4},
pages = {1324--1330},
doi = {10.1002/ps.7304}
}
EUVIMED